Hideho Okada, MD, PhD Professor of Neurological Surgery Biography Hideho Okada is a professor of Neurological Surgery at the UCSF Helen Diller Family Comprehensive Cancer Center. He is a creative physician-scientist who has developed therapeutic modalities in the laboratory, translated them into clinical protocols, and used his expertise as both scientist and clinician to assess the clinical data from ongoing trials. His work has consistently focused on immunotherapeutic strategies aimed at a daunting challenge in oncology – malignant brain tumors. Okada conducted one of the first immune gene therapy trials in patients with malignant glioma. His success in navigating the detailed regulatory processes that such trials require demonstrates his attention to detail and breadth of knowledge from basic science to clinical care. Okada’s lab work was the first to identify and fully characterize cytotoxic T-lymphocyte (CTL) epitopes for gliomas. Education & Training 1991: Nagoya University, Nagoya, Japan, MD 1996: Nagoya University, Nagoya, Japan, PhD Awards & Honors 2014: Faculty Honoree at the Annual Convocation, University of Pittsburgh 2013: Faculty Honoree at the Annual Convocation, University of Pittsburgh 2012: Innovator Award, University of Pittsburgh 2011: Faculty Honoree at the Annual Convocation, University of Pittsburgh 2010: Team Science Recognition Award, Society for Immunotherapy for Cancer; Member, American Society for Clinical Investigation (ASCI) 2009: Faculty Honoree at the Annual Convocation, University of Pittsburgh 2008: Innovator Award, University of Pittsburgh 2006-2007: Excellence in Translational Medicine Award, Journal of Translational Medicine 2003-2007: 21st Century Scientist Award, James S. McDonnell’s Foundation 2001-2006: Clinical Scientist Development Award, Doris Duke Charitable Foundation 1996-1997: Postdoctoral Scholarship, Uehara Memorial Foundation